Chronic Disease Management Market, By Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, and Others (Arthritis, etc.)), By Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth

Chronic Disease Management Market, By Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, and Others (Arthritis, etc.)), By Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth Services, and Others (Diagnostic Services, etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.

Market Dynamics:

Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global chronic disease management market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market

Detailed Segmentation-

Disease Type Insights (Revenue, USD Bn, 2019 - 2031)

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Cancer

Chronic Kidney Disease

Others (Arthritis, etc.)

Service Type Insights (Revenue, USD Bn, 2019 - 2031)

Disease Management Programs

Remote Patient Monitoring

Telehealth Services

Others (Diagnostic Services, etc.)

Delivery Mode Insights (Revenue, USD Bn, 2019 - 2031)

On-premise

Web-based

Cloud-based

End User Insights (Revenue, USD Bn, 2019 - 2031)

Hospitals

Specialty Clinics

Home Care Settings

Others (Pharmaceutical Companies, etc.)

Regional Insights (Revenue, USD Bn 2019 - 2031)

North America

U.S.

Canada

Latin America

Brazil

Argentina

Mexico

Rest of Latin America

Europe

Germany

U.K.

Spain

France

Italy

Russia

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

GCC Countries

Israel

Rest of Middle East

Africa

South Africa

North Africa

Central Africa

Key Players Insights

UnitedHealth Group

CVS Health

Cigna

Anthem, Inc.

Aetna (a CVS Health company)

Mayo Clinic

Kaiser Permanente

Humana Inc.

Teladoc Health, Inc.

McKesson Corporation

Cerner Corporation

Epic Systems Corporation

Medtronic

Abbott Laboratories

Novartis AG

Roche Holding AG

Bristol-Myers Squibb

Johns Hopkins Medicine

GE Healthcare

Philips Healthcare